These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28292717)

  • 21. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of aromatase binding in the female human brain using [
    Jonasson M; Nordeman P; Eriksson J; Wilking H; Wikström J; Takahashi K; Niwa T; Hosoya T; Watanabe Y; Antoni G; Sundström Poromaa I; Lubberink M; Comasco E
    J Neurosci Res; 2020 Nov; 98(11):2208-2218. PubMed ID: 32761874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 24. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
    Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
    Asselin MC; Montgomery AJ; Grasby PM; Hume SP
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic Evaluation of the Tau PET Radiotracer
    Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
    J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
    [No Abstract]   [Full Text] [Related]  

  • 28. Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.
    Talbot PS; Slifstein M; Hwang DR; Huang Y; Scher E; Abi-Dargham A; Laruelle M
    Neuroimage; 2012 Jan; 59(1):271-85. PubMed ID: 21782029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
    Meyer PT; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM; Hinz R
    Neuroimage; 2010 Apr; 50(3):984-93. PubMed ID: 20083209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo.
    Marner L; Gillings N; Comley RA; Baaré WF; Rabiner EA; Wilson AA; Houle S; Hasselbalch SG; Svarer C; Gunn RN; Laruelle M; Knudsen GM
    J Nucl Med; 2009 Jun; 50(6):900-8. PubMed ID: 19470850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-in-Human Assessment of
    Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
    J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [
    Courault P; Lancelot S; Costes N; Colom M; Le Bars D; Redoute J; Gobert F; Dailler F; Isal S; Iecker T; Newman-Tancredi A; Merida I; Zimmer L
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1651-1664. PubMed ID: 36656363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of 3 Novel Tau Radiopharmaceuticals,
    Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
    J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test-retest reproducibility of 18F-MPPF PET in healthy humans: a reliability study.
    Costes N; Zimmer L; Reilhac A; Lavenne F; Ryvlin P; Le Bars D
    J Nucl Med; 2007 Aug; 48(8):1279-88. PubMed ID: 17631552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. History of cigarette smoking is associated with higher limbic GABAA receptor availability.
    Stokes PR; Benecke A; Myers J; Erritzoe D; Watson BJ; Kalk N; Barros DR; Hammers A; Nutt DJ; Lingford-Hughes AR
    Neuroimage; 2013 Apr; 69():70-7. PubMed ID: 23247185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of an automatic reference region extraction for the quantification of [
    García-Lorenzo D; Lavisse S; Leroy C; Wimberley C; Bodini B; Remy P; Veronese M; Turkheimer F; Stankoff B; Bottlaender M
    J Cereb Blood Flow Metab; 2018 Feb; 38(2):333-346. PubMed ID: 28178885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Αlpha 5 subunit-containing GABA
    McGinnity CJ; Riaño Barros DA; Hinz R; Myers JF; Yaakub SN; Thyssen C; Heckemann RA; de Tisi J; Duncan JS; Sander JW; Lingford-Hughes A; Koepp MJ; Hammers A
    Brain Commun; 2021; 3(1):fcaa190. PubMed ID: 33501420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
    Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
    J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple and rapid quantification of serotonin transporter binding using [
    Gryglewski G; Rischka L; Philippe C; Hahn A; James GM; Klebermass E; Hienert M; Silberbauer L; Vanicek T; Kautzky A; Berroterán-Infante N; Nics L; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
    Neuroimage; 2017 Apr; 149():23-32. PubMed ID: 28119137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.